RARVYNLO
Live / Applied — Fourth extension granted (statement of use) (as of 26 Feb 2026)
What this means for you
Not registered yet, but its 08 Mar 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97828784
- Mark type
- Stylized text
- Filed
- 08 Mar 2023
- Published for opposition
- 02 Jan 2024
- Attorney of record
- Terrence J. McAllister
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of hematological, gastrointestinal, neuromuscular, muscular, cardiovascular, metabolic, immunological, inflammatory, oncological, ophthalmological, neurological, musculoskeletal, bone, connective tissue, dermatological, infectious, autoimmune, nephrological, hepatological, allergic, genetic, respiratory, viral diseases and disorders, and for the treatment of pain
Owner
- Regeneron Pharmaceuticals, Inc., Tarrytown, NY, US
- Regeneron Pharmaceuticals, Inc., Tarrytown, NY, US
Prosecution history
- 27 Feb 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 26 Feb 2026 — SOU EXTENSION 4 GRANTED
- 26 Feb 2026 — SOU EXTENSION 4 FILED
- 26 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 26 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 25 Jul 2025 — SOU EXTENSION 3 GRANTED
- 25 Jul 2025 — SOU EXTENSION 3 FILED
- 25 Jul 2025 — SOU TEAS EXTENSION RECEIVED
- 30 Jun 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 30 Jun 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 30 Jun 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 27 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Feb 2025 — SOU EXTENSION 2 GRANTED
- 26 Feb 2025 — SOU EXTENSION 2 FILED
- 26 Feb 2025 — SOU TEAS EXTENSION RECEIVED